Prognostic Factors for Myositis-Associated Interstitial Lung Disease

• Tomoyuki Fujisawa ,

  * E-mail: fujisawa@hama-med.ac.jp

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Hironao Hozumi,

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Masato Kono,

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Noriyuki Enomoto,

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Dai Hashimoto,

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Yutaro Nakamura,

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Naoki Inui,

  Affiliation Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯
• Koshi Yokomura,

  Affiliation Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan

  ⨯
• Naoki Koshimizu,

  Affiliation Department of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan

  ⨯
• Mikio Toyoshima,

  Affiliation Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan

  ⨯
• Toshihiro Shirai,

  Affiliation Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan

  ⨯
• Kazumasa Yasuda,

  Affiliation Department of Respiratory Medicine, Iwata City Hospital, Iwata, Japan

  ⨯
• Hiroshi Hayakawa,

  Affiliation Department of Respiratory Medicine, Tenryu Hospital, National Hospital Organization, Hamamatsu, Japan

  ⨯
• Takafumi Suda

  Affiliation Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

  ⨯